Research ArticleClinical Investigations
Head and Neck PET/CT: Therapy Response Interpretation Criteria (Hopkins Criteria)—Interreader Reliability, Accuracy, and Survival Outcomes
Charles Marcus, Anthony Ciarallo, Abdel K. Tahari, Esther Mena, Wayne Koch, Richard L. Wahl, Ana P. Kiess, Hyunseok Kang and Rathan M. Subramaniam
Journal of Nuclear Medicine September 2014, 55 (9) 1411-1416; DOI: https://doi.org/10.2967/jnumed.113.136796
Charles Marcus
1Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins School of Medicine, Baltimore, Maryland
Anthony Ciarallo
1Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins School of Medicine, Baltimore, Maryland
Abdel K. Tahari
1Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins School of Medicine, Baltimore, Maryland
Esther Mena
1Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins School of Medicine, Baltimore, Maryland
Wayne Koch
2Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins School of Medicine, Baltimore, Maryland
3Department of Oncology, Johns Hopkins School of Medicine, Baltimore, Maryland
Richard L. Wahl
1Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins School of Medicine, Baltimore, Maryland
3Department of Oncology, Johns Hopkins School of Medicine, Baltimore, Maryland
Ana P. Kiess
4Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins School of Medicine, Baltimore, Maryland; and
Hyunseok Kang
3Department of Oncology, Johns Hopkins School of Medicine, Baltimore, Maryland
Rathan M. Subramaniam
1Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins School of Medicine, Baltimore, Maryland
2Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins School of Medicine, Baltimore, Maryland
3Department of Oncology, Johns Hopkins School of Medicine, Baltimore, Maryland
5Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 55, Issue 9
September 1, 2014
Head and Neck PET/CT: Therapy Response Interpretation Criteria (Hopkins Criteria)—Interreader Reliability, Accuracy, and Survival Outcomes
Charles Marcus, Anthony Ciarallo, Abdel K. Tahari, Esther Mena, Wayne Koch, Richard L. Wahl, Ana P. Kiess, Hyunseok Kang, Rathan M. Subramaniam
Journal of Nuclear Medicine Sep 2014, 55 (9) 1411-1416; DOI: 10.2967/jnumed.113.136796
Head and Neck PET/CT: Therapy Response Interpretation Criteria (Hopkins Criteria)—Interreader Reliability, Accuracy, and Survival Outcomes
Charles Marcus, Anthony Ciarallo, Abdel K. Tahari, Esther Mena, Wayne Koch, Richard L. Wahl, Ana P. Kiess, Hyunseok Kang, Rathan M. Subramaniam
Journal of Nuclear Medicine Sep 2014, 55 (9) 1411-1416; DOI: 10.2967/jnumed.113.136796
Jump to section
Related Articles
Cited By...
- Depletion of effector regulatory T cells drives major response to induction dual immune checkpoint blockade
- 18F-FDG PET/CT Prediction of Treatment Outcomes in Human Papillomavirus-Positive, Locally Advanced Oropharyngeal Cancer Patients Receiving Deintensified Therapy: Results from NRG-HN002
- 18F-FDG PET/CT Staging of Head and Neck Cancer: Interobserver Agreement and Accuracy--Results from Multicenter ACRIN 6685 Clinical Trial
- RESISTing the Need to Quantify: Putting Qualitative FDG-PET/CT Tumor Response Assessment Criteria into Daily Practice
- Appropriate Use Criteria for 18F-FDG PET/CT in Restaging and Treatment Response Assessment of Malignant Disease
- 18F-FDG PET/CT: Therapy Response Assessment Interpretation (Hopkins Criteria) and Survival Outcomes in Lung Cancer Patients
- Molecular Imaging to Plan Radiotherapy and Evaluate Its Efficacy
- Reply: Qualitative 18F-FDG PET/CT Response Evaluation After Chemotherapy or Radiotherapy for Head and Neck Squamous Cell Carcinoma: Is There an Equivocal Group?
- Qualitative 18F-FDG PET/CT Response Evaluation After Chemotherapy or Radiotherapy for Head and Neck Squamous Cell Carcinoma: Is There an Equivocal Group?